Richard C. Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Richard C. Wang has a total of 226 co-authors. Here are the top co-authors by number of shared publications:
Eunice E. Lee
Department of Dermatology, University of Texas Southwestern Medical Center (UTSW)
16 shared publicationsGregory A. Hosler
Department of Dermatology, UT Southwestern Medical Center Dallas Texas USA
6 shared publicationsJiwoong Kim
Department of Population and Data Sciences, UT Southwestern Medical Center, Dallas, TX; and
5 shared publications- Jiwoong Kim
University of Texas Southwestern Medical Center
5 shared publications Rong Yang
Department of Dermatology, UT Southwestern Medical Center, Dallas, USA
5 shared publications- Bahir H. Chamseddin
Department of Dermatology, UT Southwestern Medical Center, Dallas, Texas
4 shared publications
Latest Publications
- 25 October 2026
- Published by Wiley in Molecular Carcinogenesis
Fusion Detection in Microsecretory Adenocarcinoma and Mucoepidermoid Carcinoma Using Chromogenic RNA In Situ Hybridization: A Promising Alternative to DNA‐Based Fluorescence In‐Situ Hybridization
Recent advances in molecular genetics have dramatically improved our understanding of the pathophysiology and classification of salivary gland tumors. The identification of recurrent oncogenic fusions has been especially helpful in distinguishing entities with overlapping histomorphology. Here, we provide the first assessment of chromogenic RNA in situ hybridization (RNA‐ISH) using BaseScope TM to detect gene fusions associated with microsecretory adenocarcinoma (MSA), MEF2C :: SS18 , and mucoepidermoid carcinoma (MEC), CRTC1 :: MAML2 , using probes specific to the exon junctions of the MEF2C :: SS18 (exon 7 of MEF2C to exon 4 of SS18 ) and CRTC1 :: MAML2 (exon 1 of CRTC1 to exon 2 of MAML2 ) fusion transcripts. Sixteen cases of MEF2C :: SS18 fusion‐positive MSA, six cases of CRTC1 :: MAML2 fusion‐positive MEC, three cases of fusion‐unknown MEC, and one case of MAML2 ‐negative MEC were included in the test cohort. Positive signal strength was assessed using a semi‐quantitative scoring method as per manufacturer guidelines. Fusion transcripts were detected by RNA‐ISH results in 14/16 cases (88%) of fusion‐positive MSAs, 3/6 cases (50%) of fusion‐positive MEC, and one case of MAML2 ‐negative MEC. Interestingly, 2 cases (67%) of fusion‐unknown MEC were also positive by RNA‐ISH for CRTC1 :: MAML2 . Positivity ranged between 1+ (one dot per cell in ≥ 5% of tumor cells in one 40× field) and 2+ (two to three dots per cell in ≥ 5% of tumor cells in one 40× field). Our results highlight the potential for ultrasensitive RNA‐ISH to be used as an alternative method of fusion detection for salivary gland malignancies with highly conserved fusion transcript exon junctions. While additional studies are needed to validate the clinical utility of the assay and to determine optimal testing conditions, RNA‐ISH may provide a means for restricted fusion analysis in cases with limited material and for pathologists without easy access to conventional molecular diagnostic testing.
- 25 October 2026
- Published by Wiley in Molecular Carcinogenesis
Fusion Detection in Microsecretory Adenocarcinoma and Mucoepidermoid Carcinoma Using Chromogenic RNA In Situ Hybridization: A Promising Alternative to DNA‐Based Fluorescence In‐Situ Hybridization
Recent advances in molecular genetics have dramatically improved our understanding of the pathophysiology and classification of salivary gland tumors. The identification of recurrent oncogenic fusions has been especially helpful in distinguishing entities with overlapping histomorphology. Here, we provide the first assessment of chromogenic RNA in situ hybridization (RNA‐ISH) using BaseScope TM to detect gene fusions associated with microsecretory adenocarcinoma (MSA), MEF2C :: SS18 , and mucoepidermoid carcinoma (MEC), CRTC1 :: MAML2 , using probes specific to the exon junctions of the MEF2C :: SS18 (exon 7 of MEF2C to exon 4 of SS18 ) and CRTC1 :: MAML2 (exon 1 of CRTC1 to exon 2 of MAML2 ) fusion transcripts. Sixteen cases of MEF2C :: SS18 fusion‐positive MSA, six cases of CRTC1 :: MAML2 fusion‐positive MEC, three cases of fusion‐unknown MEC, and one case of MAML2 ‐negative MEC were included in the test cohort. Positive signal strength was assessed using a semi‐quantitative scoring method as per manufacturer guidelines. Fusion transcripts were detected by RNA‐ISH results in 14/16 cases (88%) of fusion‐positive MSAs, 3/6 cases (50%) of fusion‐positive MEC, and one case of MAML2 ‐negative MEC. Interestingly, 2 cases (67%) of fusion‐unknown MEC were also positive by RNA‐ISH for CRTC1 :: MAML2 . Positivity ranged between 1+ (one dot per cell in ≥ 5% of tumor cells in one 40× field) and 2+ (two to three dots per cell in ≥ 5% of tumor cells in one 40× field). Our results highlight the potential for ultrasensitive RNA‐ISH to be used as an alternative method of fusion detection for salivary gland malignancies with highly conserved fusion transcript exon junctions. While additional studies are needed to validate the clinical utility of the assay and to determine optimal testing conditions, RNA‐ISH may provide a means for restricted fusion analysis in cases with limited material and for pathologists without easy access to conventional molecular diagnostic testing.
- Open Access
- 20 October 2026
- Published by American Society for Microbiology in Journal of Virology
- Vol. 100 (10)
Regulation and function of the HPV16 CircE7 RNA
High-risk human papillomaviruses (HPV), including HPV16, produce circular RNA that encompasses the E7 oncogene (circE7). CircE7 can be detected in HPV16-positive cells and tumors, is preferentially localized to the cytoplasm, is N 6 -methyladenosine (m 6 A)-modified, and can be translated into the E7 oncoprotein. Here, we explored the regulation and function of circE7. Mutation of m 6 A motifs flanking the backsplice junction revealed a single m 6 A motif to be essential for circE7 formation. Mutation of this m 6 A motif promoted linear splicing of the E6*I splice site (226^409), suggesting that linear and circular E7 splicing are inversely regulated. Additionally, mutation of an IRES-like motif in circE7 significantly decreased E7 protein expression, without having significant effects on circE7 RNA levels. Knockdown of YTHDC1, but not other m 6 A-binding proteins, decreased both circE7 RNA and protein expression. BaseScope ISH was used to confirm the expression of circE7 in head and neck squamous cell carcinoma cell lines and tumors. Using both qRT-PCR and BaseScope ISH, we found that serum and amino acid starvation significantly increased circE7. Finally, we generated an HPV16 genome with mutations in the circE7 m 6 A motif (Mut2). Stable transduction of primary keratinocytes with Mut2 confirmed the loss of circE7 and increased expression of E6*I. The Mut2 HPV16 genome exhibited significantly decreased viral replication but an increased ability to transform primary keratinocytes. Our studies reveal that the precise regulation of circE7 and E6*I by m 6 A is critical for the ability of HPV16 to infect and transform keratinocytes. IMPORTANCE: High-risk human papillomaviruses (HPVs), such as HPV16, must carefully control how much E6 and E7 proteins they make. This study shows that HPV16 toggles a single chemical tag on the viral RNA (an m⁶A mark) to control the production of early region RNAs, including a circular RNA called circE7. The same site coordinately regulates splicing of the E6*I isoform. CircE7 uses m⁶A-binding proteins to control its production and a specific sequence to promote its translation. It is present in HPV-positive cancers and can respond to nutrient starvation. Regulation of circE7 through this m 6 A site also impacted viral replication and transformation capacity, indicating that this regulatory mechanism is critical for HPV biology.
- 20 October 2026
- Published by American Society for Microbiology in Journal of Virology
- Vol. 100 (10)
Open AccessRegulation and function of the HPV16 CircE7 RNA
High-risk human papillomaviruses (HPV), including HPV16, produce circular RNA that encompasses the E7 oncogene (circE7). CircE7 can be detected in HPV16-positive cells and tumors, is preferentially localized to the cytoplasm, is N 6 -methyladenosine (m 6 A)-modified, and can be translated into the E7 oncoprotein. Here, we explored the regulation and function of circE7. Mutation of m 6 A motifs flanking the backsplice junction revealed a single m 6 A motif to be essential for circE7 formation. Mutation of this m 6 A motif promoted linear splicing of the E6*I splice site (226^409), suggesting that linear and circular E7 splicing are inversely regulated. Additionally, mutation of an IRES-like motif in circE7 significantly decreased E7 protein expression, without having significant effects on circE7 RNA levels. Knockdown of YTHDC1, but not other m 6 A-binding proteins, decreased both circE7 RNA and protein expression. BaseScope ISH was used to confirm the expression of circE7 in head and neck squamous cell carcinoma cell lines and tumors. Using both qRT-PCR and BaseScope ISH, we found that serum and amino acid starvation significantly increased circE7. Finally, we generated an HPV16 genome with mutations in the circE7 m 6 A motif (Mut2). Stable transduction of primary keratinocytes with Mut2 confirmed the loss of circE7 and increased expression of E6*I. The Mut2 HPV16 genome exhibited significantly decreased viral replication but an increased ability to transform primary keratinocytes. Our studies reveal that the precise regulation of circE7 and E6*I by m 6 A is critical for the ability of HPV16 to infect and transform keratinocytes. IMPORTANCE: High-risk human papillomaviruses (HPVs), such as HPV16, must carefully control how much E6 and E7 proteins they make. This study shows that HPV16 toggles a single chemical tag on the viral RNA (an m⁶A mark) to control the production of early region RNAs, including a circular RNA called circE7. The same site coordinately regulates splicing of the E6*I isoform. CircE7 uses m⁶A-binding proteins to control its production and a specific sequence to promote its translation. It is present in HPV-positive cancers and can respond to nutrient starvation. Regulation of circE7 through this m 6 A site also impacted viral replication and transformation capacity, indicating that this regulatory mechanism is critical for HPV biology.
- Open Access
- 1 October 2026
- Published by Elsevier in JID Innovations
- Vol. 7 (1)
Circular RNA: What they are, how they are formed, their function, and how we might be able to harness them for treatment of skin diseases
- 1 October 2026
- Published by Elsevier in JID Innovations
- Vol. 7 (1)
Open AccessCircular RNA: What they are, how they are formed, their function, and how we might be able to harness them for treatment of skin diseases
- Open Access
Subclonal IDH1/2 Mutations as a Targetable Vulnerability in Vascular Tumors
Despite extensive sequencing, the genetic etiology of sporadic angiosarcoma remains poorly defined. Maffucci syndrome, characterized by vascular tumors and elevated cancer risk, is driven by mosaic gain-of-function mutations in IDH1/2, though these have not been reported in sporadic angiosarcoma. We identify recurrent, low-variant allele frequency hotspot mutations in IDH1/2 in over half of sporadic angiosarcomas. Mutations were validated by Sanger sequencing and immunohistochemistry. Mutant IDH1 endothelial cells promote tumorigenesis through non-cell-autonomous mechanisms, secreting 2-hydroxyglutarate (2-HG) to increase growth factor and endothelial-to-mesenchymal transition gene expression, activate pAkt/pERK signaling, induce DNA methylation changes, and promote anchorage-independent growth, which are reversed by the mutant IDH1 inhibitor ivosidenib. Patients with mosaic IDH1 mutations show reduced serum 2-HG and marked tumor regression following ivosidenib treatment. The clinical efficacy of ivosidenib in vascular tumors with subclonal IDH1 mutations suggests that low VAF IDH1/2 mutations may be a targetable vulnerability in sporadic angiosarcoma.
Open AccessSubclonal IDH1/2 Mutations as a Targetable Vulnerability in Vascular Tumors
Despite extensive sequencing, the genetic etiology of sporadic angiosarcoma remains poorly defined. Maffucci syndrome, characterized by vascular tumors and elevated cancer risk, is driven by mosaic gain-of-function mutations in IDH1/2, though these have not been reported in sporadic angiosarcoma. We identify recurrent, low-variant allele frequency hotspot mutations in IDH1/2 in over half of sporadic angiosarcomas. Mutations were validated by Sanger sequencing and immunohistochemistry. Mutant IDH1 endothelial cells promote tumorigenesis through non-cell-autonomous mechanisms, secreting 2-hydroxyglutarate (2-HG) to increase growth factor and endothelial-to-mesenchymal transition gene expression, activate pAkt/pERK signaling, induce DNA methylation changes, and promote anchorage-independent growth, which are reversed by the mutant IDH1 inhibitor ivosidenib. Patients with mosaic IDH1 mutations show reduced serum 2-HG and marked tumor regression following ivosidenib treatment. The clinical efficacy of ivosidenib in vascular tumors with subclonal IDH1 mutations suggests that low VAF IDH1/2 mutations may be a targetable vulnerability in sporadic angiosarcoma.
- Open Access
Regulation and Function of the HPV16 CircE7 RNA
High-risk human papillomaviruses (HPV), including HPV16, produce circular RNA that encompass the E7 oncogene (circE7). CircE7 can be detected in HPV16-positive cells and tumors, is preferentially localized to the cytoplasm, is N 6 -methyladenosine (m 6 A) modified and can be translated to produce the E7 oncoprotein. Here, we explored the regulation and function of circE7. Mutation of m 6 A motifs flanking the backsplice junction revealed a single essential m 6 A motif to be essential for circE7 formation. Mutation of this m 6 A motif promoted linear splicing of the E6*I splice site (226^409), suggesting that linear and circular E7 splicing are inversely regulated. Additionally, mutation of an IRES-like motif in circE7 significantly decreased E7 protein expression, without having significant effects on circE7 RNA levels. Knockdown of YTHDC1, but not other m 6 A-binding proteins, decreased both circE7 RNA and protein expression. BaseScope ISH was used to confirm the expression of circE7 in HPV positive head and neck squamous cell carcinoma cell lines. Using both qRT-PCR and BaseScope ISH, we found that serum and amino acid starvation significantly increased circE7 levels. Finally, we generated a HPV16 genome with two point mutations in the circE7 m 6 A motif (Mut2). Stable transduction of primary keratinocytes with Mut2 confirmed the loss of circE7 and increased expression of E6*I. The Mut2 HPV16 genome exhibited significantly decreased viral replication but an increased ability to transform primary keratinocytes. Our studies reveal that the precise regulation of circE7 and E6*I by m 6 A are critical for the ability of HPV16 to infect and transform keratinocytes.
Open AccessRegulation and Function of the HPV16 CircE7 RNA
High-risk human papillomaviruses (HPV), including HPV16, produce circular RNA that encompass the E7 oncogene (circE7). CircE7 can be detected in HPV16-positive cells and tumors, is preferentially localized to the cytoplasm, is N 6 -methyladenosine (m 6 A) modified and can be translated to produce the E7 oncoprotein. Here, we explored the regulation and function of circE7. Mutation of m 6 A motifs flanking the backsplice junction revealed a single essential m 6 A motif to be essential for circE7 formation. Mutation of this m 6 A motif promoted linear splicing of the E6*I splice site (226^409), suggesting that linear and circular E7 splicing are inversely regulated. Additionally, mutation of an IRES-like motif in circE7 significantly decreased E7 protein expression, without having significant effects on circE7 RNA levels. Knockdown of YTHDC1, but not other m 6 A-binding proteins, decreased both circE7 RNA and protein expression. BaseScope ISH was used to confirm the expression of circE7 in HPV positive head and neck squamous cell carcinoma cell lines. Using both qRT-PCR and BaseScope ISH, we found that serum and amino acid starvation significantly increased circE7 levels. Finally, we generated a HPV16 genome with two point mutations in the circE7 m 6 A motif (Mut2). Stable transduction of primary keratinocytes with Mut2 confirmed the loss of circE7 and increased expression of E6*I. The Mut2 HPV16 genome exhibited significantly decreased viral replication but an increased ability to transform primary keratinocytes. Our studies reveal that the precise regulation of circE7 and E6*I by m 6 A are critical for the ability of HPV16 to infect and transform keratinocytes.
- Open Access
- 7 July 2025
- Published by Elsevier in JID Innovations
- Vol. 5 (6) , 100398
Characterization of Malignant Adnexal Tumors of the Head and Neck by Targeted Analysis of Cancer Genes and Human Papillomavirus 42
- 7 July 2025
- Published by Elsevier in JID Innovations
- Vol. 5 (6) , 100398
Open AccessCharacterization of Malignant Adnexal Tumors of the Head and Neck by Targeted Analysis of Cancer Genes and Human Papillomavirus 42
- Open Access
- 28 October 2024
- Published by Elsevier in JID Innovations
- Vol. 5 (1) , 100322
Identification of Associations with Dermatologic Diseases through a Focused GWAS of the UK Biobank
- 28 October 2024
- Published by Elsevier in JID Innovations
- Vol. 5 (1) , 100322
Open AccessIdentification of Associations with Dermatologic Diseases through a Focused GWAS of the UK Biobank
- 17 September 2024
- Published by Wolters Kluwer Health in The American Journal of Dermatopathology
- Vol. 46 (12) , 890-893
Whole-Exome Sequencing Identifies Novel and Previously Reported Mutations in a Case of Intravascular B-Cell Lymphoma
- 17 September 2024
- Published by Wolters Kluwer Health in The American Journal of Dermatopathology
- Vol. 46 (12) , 890-893
Whole-Exome Sequencing Identifies Novel and Previously Reported Mutations in a Case of Intravascular B-Cell Lymphoma
- 13 September 2024
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 145 (4) , 780-789
Nucleic Acid Therapy for the Skin
- 13 September 2024
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 145 (4) , 780-789
Nucleic Acid Therapy for the Skin
- Open Access
- 6 January 2024
- Published by Elsevier in JAAD Case Reports
- Vol. 45, 117-122
West Nile virus encephalitis presenting with a vesicular dermatitis
- 6 January 2024
- Published by Elsevier in JAAD Case Reports
- Vol. 45, 117-122
Open AccessWest Nile virus encephalitis presenting with a vesicular dermatitis